期刊文献+

高血压中J型曲线的回顾与分析 被引量:6

Reviews and Analyses of J-Curve in Hypertension
下载PDF
导出
摘要 过去30多年里,关于血压与心血管事件之间的J型曲线一直都是备受关注的话题。众所周知,高血压是心血管疾病最重要的危险因素之一,积极有效的降压治疗可以显著降低心血管事件发生的风险。然而却有大量研究发现,舒张压的降低,也伴随着冠心病和其他不利后果的风险增高。这种效应在接受治疗的冠心病患者中更加显著。因此,强化降压的理念受到了巨大的冲击,而降压目标究竟该如何选择,再一次成为了内科医生们所面临的难题。对高血压中的J型曲线的回顾与分析会为我们制定科学合理的降压策略提供依据。 During the past 30 years,the J-curve between blood pressure and cardiovascular events has been a subject of much concern.As we know,hypertension is one of the most important risk factors in coronary artery disease;a risk that could be significantly lowered by active and effective antihypertensive treatments.However,as observed in numerous studies,we have noticed that lowering the diastolic pressure has also brought greater risk of coronary heart disease and adverse outcomes.This effect is even more pronounced in patients with underlying coronary artery disease.As a result aggressive blood pressure-lowering has been impacted,and physicians are once again stuck for what to choose as a target level.Reviews and analyses of the J-curve in hypertension provide a basis for rational medication.
作者 陈驰 陈明
出处 《心血管病学进展》 CAS 2011年第3期361-365,共5页 Advances in Cardiovascular Diseases
关键词 高血压 血压 心血管疾病 J型曲线 降压治疗 hypertension blood pressure coronary artery disease J-curve antihypertensive treatment
  • 相关文献

参考文献31

  • 1Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension [ J ]. Lancet, 1979, 1 : 861- 865.
  • 2Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure[ J ]. Lancet, 1987, 1 : 581-554.
  • 3Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous[ J] ? JAMA, 1991, 265 : 489-495.
  • 4Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data [J]. Ann Intern Med, 2002, 136(6) : 438448.
  • 5Kannel WB, Wilson PW, Nam BH, et al. A likely explanation for the J-curve of blood pressure cardiovascular risk[ J ]. Am J Cardiol, 2004, 94: 380-384.
  • 6Sleight P, Redon J, Verdecchia P, et al. Prognostic value of blood pressure in patients with high vascular risk in the ongoing telmisartan alone and in combination with ramipril global endpoint trial study[J]. J Hypertens, 2009, 27(7) : 1360-1369.
  • 7Wagner M, Goetghebeur M, Merikle E, et al. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada [ J ]. Can J Clin Pharmaeol, 2009, 16(2) : 331-345.
  • 8Grimm RH, Flack JM, Grandits GA, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group[J]. JAMA, 1996, 275(20): 1549-1556.
  • 9Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal resuits of the Hypertension Optimal Treatment (HOT) randomized trial[J]. Lancet, 1998, 351: 1775-1762.
  • 10Cruiekshank JM. Antihypertensive treatment and the J-curve[J]. Cardiovasc Drugs Ther, 2000, 14: 373-379.

同被引文献58

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部